Felipe A. Montellano
Research in cooperation with the Interdisciplinary Center for Clinical Research at the University of Würzburg / Research within the Clinician-Scientist Programme UNION –CVD (German Research Foundation)
Dr. med. Felipe A. Montellano
| Phone: | +49 931 / 201 47318 |
| Fax: | +49 931 / 201 647310 |
| E-Mail: | montellano_f@ukw.de |
Short CV
| since 2020 | Resident. Department of Neurology, Würzburg University Hospital |
| since 2017 | Research Asssociate. Institute of Clinical Epidemiology and Biometry of the University of Würzburg (MD/PhD Fellow of the Interdisciplinary Center for Clinical Research at the Würzburg University Hospital) |
| since 2016 | European Master in Stroke Medicine. Danube-University Krems. Austria (Scholar of the European Stroke Organisation) |
| 2015-2017 | Medical Doctoral Studies. Institute of Physiology and Pathophysiology. Neurovascular Research Group. Medical Faculty of the University of Heidelberg. (Prof. Dr. Hugo Marti) |
| 2014-2015 | Resident in Emergency Medicine, Clínica Dávila and Clínica INDISA. Santiago, Chile. |
| 2009 | Honours Scholarship, Faculty of Medicine of the Universidad de los Andes. Santiago, Chile |
| 2007-2013 | Medical School. Faculty of Medicine of the Universidad de los Andes. Santiago, Chile. |
Research interests
Acute stroke therapy, neurocritical care, emergency medicine.
Main Publications in recent years
Hartung T, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Enders M, Geritz J, Haeusler KG, Heuschmann PU, Hildesheim H, Hinz A, Hopff S, Horn A, Krawczak M, Krist L, Kudelka J, Lieb W, Maetzler C, Mehnert-Theuerkauf A, Montellano F, Morbach C, Schmidt S, Schreiber S, Steigerwald F, Störk S, Maetzler W, Finke C:
Fatigue and cognitive impairment after COVID-19: A prospective multicenter study.
eClinicalMedicine, Volume 53, 2022, 101651. DOI: 10.1016/j.eclinm.2022.101651
Felipe A Montellano, Kathrin Ungethüm, Laura Ramiro, Aliona Nacu, Simon Hellwig, Felix Fluri, William N Whiteley, Alejandro Bustamante, Joan Montaner, Peter U Heuschmann
Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis: A Systematic Review
Stroke. 2021 Jan 12;STROKEAHA120029232. doi: 10.1161/STROKEAHA.120.029232. Online ahead of print.
Peter U. Heuschmann MD, MPH , Felipe A. Montellano MD , Kathrin Ungethüm MSc, Viktoria Rücker MSc, Silke Wiedmann PhD, Daniel Mackenrodt MD, Anika Quilitzsch BA, Timo Ludwig, Peter Kraft MD, Judith Albert MD, Caroline Morbach MD, Stefan Frantz MD, Stefan StörkMD, PhD, Karl Georg Haeusler MD and Christoph Kleinschnitz MD
Prevalence and determinants of systolic and diastolic cardiac dysfunction and heart failure in acute ischemic stroke patients: The SICFAIL study
ESC Heart Failure (2020) Published online in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/ehf2.13145
Gruneberg D, Montellano FA, Plaschke K, Li L, Marti HH, Kunze R.
Neuronal prolyl-4-hydroxylase 2 deficiency improves cognitive abilities in a murine model of cerebral hypoperfusion.
Exp Neurol. 2016 Dec;286:93-106.
Carreño JE, Verdugo FJ, Contreras F, Montellano FA, Veloso S, Schalper KA, Sandoval M, Villanueva S, Marusic E, Irarrazabal CE.
Spironolactone inhibits the activity of the Na+/H+ exchanger in the aorta of mineralocorticoid-induced hypertensive rats.
J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):1225-31.
